# Encora Therapeutics' MIT-Born Tremor Device Gets FDA Approval

> MIT student project becomes FDA-approved tremor treatment after nine years.
- Title: Encora Therapeutics' MIT-Born Tremor Device Gets FDA Approval
- Summary: MIT student project becomes FDA-approved tremor treatment after nine years. Encora Therapeutics' tremor device, developed from a 2017 MIT class project…
- Keywords: encora therapeutics, mit, essential tremor, fda clearance, tremor device, 2026, parks disease, startups, business, Encora, Therapeutics', MIT-Born
- Source: Pulse 2.0 — https://pulse2.com/encora-therapeutics-mit-born-tremor-device-receives-fda-clearance
- Author: Amit Chowdhry
- Published: 2026-10-10T19:56:49+00:00
- Read time: 1 min
- Topics: encora therapeutics, mit, essential tremor, fda clearance, tremor device, 2026, parks disease, startups, business
## MIT Student Project
Encora Therapeutics developed an FDA-cleared wearable treatment for essential tremor from a prototype created by MIT students in 2017.
## Patient Demonstration
A Parkinson's patient demonstrated the prototype and experienced a dramatic reduction in hand tremor during the team's final presentation.
## FDA Clearance
In February 2026, the U.S. Food and Drug Administration cleared the device for adults with essential tremor, nine years after the original MIT demonstration.
## Key takeaway

Encora Therapeutics' tremor device, developed from a 2017 MIT class project, received FDA clearance for essential tremor treatment in February 2026.